Mironid
David is an expert in cyclic nucleotide signaling and phosphodiesterase biology, with a proven track record of driving innovative R&D, biomarker, and drug development programs. He has pioneered biological research and development within institutes in the UK and the US and is driven by a passion for translating scientific discovery into a real-world benefit.
Mironid
Mironid is a drug discovery company focused on therapeutics for degenerative kidney diseases, chronic inflammatory diseases, and cancer.